Related Experiment Video
Updated: Jun 29, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
The persistent inflammation in COPD: is autoimmunity the core mechanism?
Ling-Ling Dong1, Zheng-Yuan Liu1, Kai-Jun Chen1
1Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Autoimmune responses play a key role in chronic obstructive pulmonary disease (COPD) progression by driving persistent airway inflammation. Understanding these autoimmune mechanisms is crucial for developing new COPD treatments.
Area of Science:
- Pulmonary Medicine
- Immunology
- Pathogenesis Research
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue characterized by irreversible airflow limitation and chronic respiratory symptoms.
- Key pathological features include persistent airway inflammation and lung tissue destruction, but underlying disease mechanisms are not fully understood.
- Sustained inflammation is central to COPD progression, highlighting the need to investigate self-perpetuating inflammatory pathways.
Purpose of the Study:
- To review the evidence for autoimmune processes in COPD.
- To examine potential mechanisms by which autoimmunity drives chronic inflammation in COPD.
- To interpret COPD's clinical features through the lens of autoimmunity.
Main Methods:
- Literature review of studies investigating autoimmune responses in COPD.
- Analysis of proposed mechanisms linking autoimmunity to COPD pathogenesis.
- Correlation of autoimmune findings with clinical manifestations of COPD.
Main Results:
- Growing evidence supports the involvement of autoimmune responses in COPD.
- Autoimmunity is implicated as a critical factor in maintaining the chronic inflammation characteristic of COPD.
- Autoimmune mechanisms offer a potential framework for understanding COPD's clinical presentation.
Conclusions:
- Autoimmune processes are increasingly recognized as significant drivers of COPD.
- Further research into the specific autoimmune mechanisms in COPD is warranted.
- An autoimmune perspective may provide novel insights into COPD management and treatment strategies.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

